Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction. - Wikidata - wikimedia - TriplyDB

Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.

Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.

http://www.wikidata.org/entity/Q46446883

about

Increased cytochrome P4502E1 expression and altered hydroxyeicosatetraenoic acid formation mediate diabetic vascular dysfunction: rescue by guanylyl-cyclase activation.Identification of free nitric oxide radicals in rat bone marrow: implications for progenitor cell mobilization in hypertension The effects of 17-methoxyl-7-hydroxy-benzene-furanchalcone on the pressure overload-induced progression of cardiac hypertrophy to cardiac failure.Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling.The nitric oxide donor pentaerythritol tetranitrate reduces platelet activation in congestive heart failure.Aquaporin-1 Deficiency Protects Against Myocardial Infarction by Reducing Both Edema and Apoptosis in Mice Exercise training improves vascular mitochondrial function.Nitrite therapy improves left ventricular function during heart failure via restoration of nitric oxide-mediated cytoprotective signaling.Pathological ventricular remodeling: therapies: part 2 of 2.Potential novel pharmacological therapies for myocardial remodelling.Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation.Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction.Modulating the nitric oxide - cyclic GMP pathway in the pressure-overloaded left ventricle and group II pulmonary hypertension.Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies.Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy.Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.Non-cardiomyocyte microRNAs in heart failure.Angiogenesis in the infarcted myocardium.Endothelial progenitor cells: from senescence to rejuvenation.Autonomic Dysregulation as a Therapeutic Target for Acute HF.Targeting vascular (endothelial) dysfunction.Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease.MiR-216a: a link between endothelial dysfunction and autophagy.Inhibition of TGF-β1 by eNOS gene transfer provides cardiac protection after myocardial infarction.Aminoethyl nitrate--the novel super nitrate?Exercise training upregulates nitric oxide synthases in the kidney of rats with chronic heart failure.Inhibition of platelet activation in rats with severe congestive heart failure by a novel endothelial nitric oxide synthase transcription enhancer.The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics.Mechanistic studies of AVE3085 against homocysteine in endothelial protection.

P2860

Q34024378-B3048648-8C86-4E2E-8FEC-4EAD1595C7B3 Q34647889-46AC6B36-71FD-487F-88EB-C3762B775710 Q35119055-607D61D7-A9DF-4683-888B-224B100E90C7 Q35216447-05474C8F-5692-42AE-AE22-DCE3AFF988AC Q35619474-B3367454-EC95-4489-9ABE-270443FE3DB0 Q36035521-D8FFB61A-2EA5-4132-AD11-8674F763688E Q36902422-6A4A6878-BC78-4F4F-B1EC-14D44AD9A6CF Q37090170-B82B725B-4896-4FFE-BFD5-1E6840F23FC3 Q37312758-9F9C5759-D4DC-49E4-95DA-F61B32075CCB Q37329709-AAA0ED64-AF6F-40F7-91F2-F02E25E49F29 Q37775559-C2190E3C-9831-400C-A40F-111D2F41AA60 Q37780204-5DF06FEF-5549-4F87-ACF9-1BD6B567BDF5 Q37799652-E999B64F-302A-435F-8F34-F5BEA44CF5E9 Q37835753-F76F9D53-22F1-4387-BF00-31DC86BBA122 Q37881801-29BE9A6A-2FA1-4A8F-8934-55EC22E1EC8A Q37968218-6DA91625-B79A-4F1F-A0D5-13F06F8309CD Q37969738-FBC9BAD3-4115-4699-B695-A03BE234B4CC Q38032602-7DB04AAC-4D93-48CA-BD47-682052E182E2 Q38248787-F13775F6-1178-4784-BFD8-20309720AD0B Q38573100-F86BBA87-7A39-4EBB-9A27-93AA696FB46F Q38836199-7F44E7BD-94B0-4254-9816-16FD8D2A7690 Q39209626-439BE818-17DB-4D67-8722-880914927CF7 Q40138320-47AC0EF3-6D3A-4D82-9D77-4BC906FC0F02 Q41169833-5A80ECE3-AF2A-4BF5-B20D-0F9C7E11A329 Q42268160-C2F069CF-2B58-480A-BF43-4C21931A7C2A Q44889332-8BFC9D9B-CC02-4550-815E-927CB05F2317 Q46133367-C1EC7EB5-A0B5-42B9-A7D1-9FE572102C93 Q47667272-F23316FD-5446-4B1C-8630-CB63066C15E5 Q48023486-885CA1EF-DAB1-463C-AF7E-25A9704B5CAD

P2860

Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.

http://www.wikidata.org/entity/Q46446883

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Improvement in left ventricula ...... imental myocardial infarction.

@en

Improvement in left ventricula ...... imental myocardial infarction.

@nl

type

label

Improvement in left ventricula ...... imental myocardial infarction.

@en

Improvement in left ventricula ...... imental myocardial infarction.

@nl

prefLabel

Improvement in left ventricula ...... imental myocardial infarction.

@en

Improvement in left ventricula ...... imental myocardial infarction.

@nl

P1433

Q46446883-6718307D-CD65-400F-8CD2-96B02624CBC9

P1476

Q46446883-F22C1E2A-3729-414D-BDE7-0C821A2B4B8F

P2093

Q46446883-1049618C-E345-488F-A6FA-27B9DA62307E

Q46446883-4209DF25-FFA4-448E-9963-133D650E9BB6

Q46446883-5C75E3B3-CFFF-49FA-ABF5-7856D8CD17E7

Q46446883-978EE6B4-F122-4026-B6F3-27791E8C7B7D

Q46446883-9CCF1C32-FE2F-4469-BE47-F2E9E49B018E

Q46446883-A1026342-094D-440B-9D11-6FDFD39A42EF

Q46446883-B83BC592-C5C9-44F6-8F40-EF967FD34951

Q46446883-BF7ECE15-D7D3-4DB6-8613-4235F740E53C

P304

Q46446883-F9100D84-C8C1-42D2-B7C6-11AEC4C66701

P31

Q46446883-57071C4F-FE73-47CD-87ED-ECCADC752509

P356

Q46446883-40D07E2D-D9BE-47AD-998A-9279017E0B80

P407

Q46446883-6DCFF40A-A15F-4738-9B38-2D1731DFD50C

P433

Q46446883-AAE1DA30-346E-4878-A1AE-064BBEAE26A7

P478

Q46446883-5A0DF2B9-89C9-46DE-9B8B-4B92FA9AC9B9

P50

Q46446883-94F985E2-FB7E-4AAF-9D23-4C7A467BC8C5

P577

Q46446883-D94C9ADC-A950-454F-A6D5-A833D4012550

P698

Q46446883-58A78A10-18A3-4066-9591-7A43BD76A9F4

P921

Q46446883-2BE8D99D-0D3C-4C2C-82A8-3E65CAB61E8A

Q46446883-E6DF900C-FA76-43EC-AFF0-C66CA31DF6EC

P356

CIRCULATIONAHA.107.717702

P1433

P1476

Improvement in left ventricula ...... imental myocardial infarction.

@en

P2093

Daniela Fraccarollo

http://www.w3.org/2001/XMLSchema#string

Dimitrios Tsikas

http://www.w3.org/2001/XMLSchema#string

Georg Ertl

http://www.w3.org/2001/XMLSchema#string

Hartmut Ruetten

http://www.w3.org/2001/XMLSchema#string

Johann Bauersachs

http://www.w3.org/2001/XMLSchema#string

Julian D Widder

http://www.w3.org/2001/XMLSchema#string

Michael Hoffmann

http://www.w3.org/2001/XMLSchema#string

Paolo Galuppo

http://www.w3.org/2001/XMLSchema#string

P304

818-827

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.107.717702

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18678774

http://www.w3.org/2001/XMLSchema#string

P921